Bridging expectations and science: a roadmap for the future of longevity interventions

Area of Science:

• Gerontology and Regenerative Medicine
• Translational Science
• Biomedical Research

Background:

• The field of longevity interventions is rapidly expanding, fueled by scientific progress and public interest.
• Currently, no longevity intervention is clinically validated or ready for widespread adoption, creating a gap between expectations and reality.
• Existing enthusiasm for longevity research outpaces its clinical translation due to a lack of validated interventions, regulatory standards, and biomarkers.

Purpose of the Study:

• To explore consumer priorities and information needs regarding longevity interventions.
• To identify psychological, financial, and practical barriers to the adoption of longevity interventions.
• To propose strategies for overcoming these barriers and advancing longevity research toward clinical readiness.

Main Methods:

• Literature review and synthesis of current research on longevity interventions.
• Analysis of consumer perspectives and barriers to adoption.
• Development of a roadmap for clinical translation of longevity science.

Main Results:

• Consumers prioritize interventions based on specific criteria, but their understanding often lags behind scientific evidence.
• Significant barriers, including psychological, financial, and practical challenges, hinder the adoption of longevity interventions.
• A clear distinction between scientifically supported and unproven longevity approaches is crucial for public understanding.

Conclusions:

• Clinical translation of longevity interventions requires addressing the gap between public perception and scientific evidence.
• Overcoming adoption barriers and establishing clear regulatory pathways are essential for safe and effective clinical implementation.
• A roadmap is proposed to guide the transition of longevity interventions from research to clinical practice, ensuring realistic expectations and evidence-based approaches.